(Q73202471)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083287%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083287%20AND%20SRC:MED&resulttype=core&format=json

juvenile rheumatoid arthritis

2 November 2019

main subject

1 reference

Bloom BJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083287%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083287%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083287%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083287%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083287%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

2606-2608

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11083287%20AND%20SRC:MED&resulttype=core&format=json

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200011%2943%3A11%3C2606%3A%3AAID-ANR31%3E3.0.CO%3B2-X

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200011%2943%3A11%3C2606%3A%3AAID-ANR31%3E3.0.CO%3B2-X

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200011%2943%3A11%3C2606%3A%3AAID-ANR31%3E3.0.CO%3B2-X

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200011%2943%3A11%3C2606%3A%3AAID-ANR31%3E3.0.CO%3B2-X

Autoimmune skin rashes associated with etanercept for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200011%2943%3A11%3C2606%3A%3AAID-ANR31%3E3.0.CO%3B2-X

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200011%2943%3A11%3C2606%3A%3AAID-ANR31%3E3.0.CO%3B2-X

Juvenile rheumatoid arthritis in children with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200011%2943%3A11%3C2606%3A%3AAID-ANR31%3E3.0.CO%3B2-X

Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200011%2943%3A11%3C2606%3A%3AAID-ANR31%3E3.0.CO%3B2-X

10.1002/1529-0131(200011)43:11<2606::AID-ANR31>3.0.CO;2-X

21 January 2018

Identifiers

DOI

0 references

1 reference